Abstract
Head and neck squamous cell carcinoma (HNSCC) accounts for around 6 % of all cancers in the USA. Few of the greatest obstacles in HNSCC include development of secondary primary tumor, resistance and toxicity associated with the conventional treatments, together decreasing the overall 5-year survival rate in HNSCC patients to ≤50 %. Radiation and chemotherapy are the conventional treatment options available for HNSCC patients at both early and late stage of this cancer type malignancy. Unfortunately, patients response poorly to these therapies leading to relapsed cases, which further, emphasizes the need of additional strategies for the prevention/intervention of both primary and the secondary primary tumors post-HNSCC therapy. In recent years, growing interest has focused on the use of natural products or their analogs to reduce the incidence and mortality of cancer, leading to encouraging results. Resveratrol, a component from grape skin, is one of the well-studied agents with a potential role in cancer chemoprevention and other health benefits. As an anticancer agent, resveratrol suppresses metabolic activation of pro-carcinogens to carcinogens by modulating the metabolic enzymes responsible for their activation, and induces phase II enzymes, thus, further detoxifying the effect of pro-carcinogens. Resveratrol also inhibits cell growth and induces cell death in cancer cells by targeting cell survival and cell death regulatory pathways. Growing evidence also suggest that resveratrol directly binds to DNA and RNA, activates antioxidant enzymes, prevents inflammation, and stimulates DNA damage checkpoint kinases affecting genomic integrity more specifically in malignant cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 4NQO:
-
4-Nitroquinoline 1-oxide
- ADH:
-
Alcohol dehydrogenase
- ALDH:
-
Aldehyde dehydrogenase
- AP-1:
-
Activator protein 1
- ARE:
-
Antioxidant response element
- ATM:
-
Ataxia telangiectasia mutated
- ATR:
-
Ataxia telangiectasia-Rad3-related
- B[A]P:
-
Benzo[a]pyrene
- BER:
-
Base excision repair
- Brca1:
-
Breast cancer gene 1
- Cdc25C:
-
Cell division cycle 25C
- CDKs:
-
Cyclin dependent kinases
- Chk1/2:
-
Checkpoint kinase 1/2
- COX2:
-
Cyclooxygenase 2
- CYP450:
-
Cytochrome P450s
- DMBA:
-
7,12-Dimethylbenz[α]anthracene
- DSBs:
-
Double strand break
- EGFR:
-
Epidermal growth factor receptor
- Egr 1:
-
Early growth response 1
- EMT:
-
Epithelial mesenchymal transition
- FA:
-
Fanconi anemia
- GSH:
-
Glutathione
- HNSCC:
-
Head and neck squamous cell carcinoma
- HPV:
-
Human papilloma virus
- HRR:
-
Homologous recombination repair
- IGFR:
-
Insulin-like growth factor receptor
- iNOS:
-
Inducible nitric oxide synthetase
- JNK:
-
c-Jun N-terminal kinase
- MAPK:
-
Mitogen-activated protein kinases
- MCM:
-
Minichromosome maintenance
- MMPs:
-
Metalloproteinases
- MMR:
-
Mismatch repair
- mTOR:
-
Mammalian target of rapamycin
- NER:
-
Nucleotide excision repair
- NF-kB:
-
Nuclear factor kappa B
- NHEJ:
-
Non-homologous end joining
- NNK:
-
4-Methylnitrosamine-1-(3-pyridyl)-1-butanone
- P53:
-
Protein 53
- PARP:
-
Poly (ADP-ribose) polymerases
- PCNA:
-
Proliferating cell nuclear antigen
- RA:
-
Retinoic acid
- Rb:
-
Retinoblastoma protein
- Res:
-
Resveratrol
- ROS/RNS:
-
Reactive oxygen species/reactive nitrogen species
- SPT:
-
Secondary primary tumor
- SSBs:
-
Single strand break
- STAT3:
-
Signal transducer and activator of transcription 3
References
Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71(10):1397–1421
Balbo S, Meng L et al (2012) Kinetics of DNA adduct formation in the oral cavity after drinking alcohol. Cancer Epidemiol Biomarkers Prev 21(4):601–608
Basso E, Fiore M et al (2013) Effects of resveratrol on topoisomerase II-alpha activity: induction of micronuclei and inhibition of chromosome segregation in CHO-K1 cells. Mutagenesis 28(3):243–248
Bo S, Ciccone G et al (2013) Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20(10):1323–1331
Brown GC, Borutaite V (2011) There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion 12(1):1–4
Buonocore D, Lazzeretti A et al (2012) Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy evaluated in a placebocontrolled, double-blind study. Clin Cosmet Investig Dermatol 5:159–165
Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87(1):14–32
Connell PP, Jayathilaka K et al (2006) Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol 28(5):1113–1119
Cui R, Kamatani Y et al (2009) Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137(5):1768–1775
Day GL, Blot WJ et al (1994) Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 86(2):131–137
De Groote D, Van Belleghem K et al (2012) Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects. Ann Nutr Metab 61(1):15–24
Derry MM, Raina K et al (2013) Identifying molecular targets of lifestyle modifications in colon cancer prevention. Front Oncol 3:119
Dudek AZ, Lesniewski-Kmak K et al (2009) Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor. Br J Cancer 100(9):1379–1384
Ferlay J, Shin HR et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Fortune JM, Osheroff N (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 64:221–253
Fouret P, Monceaux G et al (1997) Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 123(5):513–516
Freedman ND, Schatzkin A et al (2007) Alcohol and head and neck cancer risk in a prospective study. Br J Cancer 96(9):1469–1474
Freudlsperger C, Burnett JR et al (2010) EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opin Ther Targets 15(1):63–74
Furgason JM, Bahassi M et al (2012) Targeting DNA repair mechanisms in cancer. Pharmacol Ther 137(3):298–308
Garaycoechea JI, Crossan GP et al (2012) Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489(7417):571–575
Gatz SA, Wiesmuller L (2008) Take a break—resveratrol in action on DNA. Carcinogenesis 29(2):321–332
Gillison ML, Koch WM et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720
Hira A, Yabe H et al (2013) Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 122(18):3206–3209
Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366–374
Hong WK, Endicott J et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315(24):1501–1505
Howard JD, Lu B et al (2012) Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation. Oral Oncol 48(1):10–17
Howells LM, Berry DP et al (2011) Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 4(9):1419–1425
Irish JC, Bernstein A (1993) Oncogenes in head and neck cancer. Laryngoscope 103(1 Pt 1):42–52
Ishiji T (2000) Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 27(2):73–86
Jelski W, Kutylowska E et al (2011) Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer. J Gastrointestin Liver Dis 20(3):255–259
Kundu SK, Nestor M (2012) Targeted therapy in head and neck cancer. Tumour Biol 33(3):707–721
Lachenmeier DW, Monakhova YB (2011) Short-term salivary acetaldehyde increase due to direct exposure to alcoholic beverages as an additional cancer risk factor beyond ethanol metabolism. J Exp Clin Cancer Res 30:3
Lanzilli G, Fuggetta MP et al (2006) Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol 28(3):641–648
Leemans CR, Braakhuis BJ et al (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22
Lenaz G (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52(3–5):159–164
Leon-Galicia I, Diaz-Chavez J et al (2013) Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. Eur J Cancer Prev 22(1):11–20
Maacke H, Opitz S et al (2000) Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer 88(6):907–913
Maiorano D, Lutzmann M et al (2006) MCM proteins and DNA replication. Curr Opin Cell Biol 18(2):130–136
Markus MA, Marques FZ et al (2011) Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs. PLoS One 6(12):e28926
Martins LA, Coelho BP et al (2014) Resveratrol induces pro-oxidant effects and time-dependent resistance to cytotoxicity in activated hepatic stellate cells. Cell Biochem Biophys 68(2):247–257
Mitra A, Jameson C et al (2009) Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology 55(6):696–704
Nassiri-Asl M, Hosseinzadeh H (2009) Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds. Phytother Res 23(9):1197–1204
Nguyen SA, Walker D et al (2012) mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol 13(1):71–81
O’Neil N, Rose A (2006) DNA repair. WormBook, pp 1–12
Ohba S, Fujii H et al (2009) Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. J Oral Pathol Med 39(1):74–78
Paglin S, Hollister T et al (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61(2):439–444
Pavlov YI, Shcherbakova PV et al (2006) Roles of DNA polymerases in replication, repair, and recombination in eukaryotes. Int Rev Cytol 255:41–132
Petti S (2009) Lifestyle risk factors for oral cancer. Oral Oncol 45(4–5):340–350
Poeta ML, Manola J et al (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357(25):2552–2561
Radhakrishnan S, Reddivari L et al (2011) Resveratrol potentiates grape seed extract induced human colon cancer cell apoptosis. Front Biosci (Elite Ed) 3:1509–1523
Radojicic J, Zaravinos A et al (2012) HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. Int J Biol Markers 27(1):1–12
Rakoff-Nahoum S (2006) Why cancer and inflammation? Yale J Biol Med 79(3–4):123–130
Roy S, Kaur M et al (2007) p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther 6(10):2696–2707
Rusin P, Olszewski J et al (2009) Comparative study of DNA damage and repair in head and neck cancer after radiation treatment. Cell Biol Int 33(3):357–363
Sanchez-Alvarez R, Martinez-Outschoorn UE et al (2013) Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle 12(2):289–301
Sankaranarayanan R, Masuyer E et al (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18(6B):4779–4786
Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7(8):599–612
Sharafinski ME, Ferris RL et al (2010) Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32(10):1412–1421
Siegel R, Naishadham D et al (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Signorelli P, Ghidoni R (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16(8):449–466
Smith J, Tho LM et al (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108:73–112
Tome-Carneiro J, Larrosa M et al (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19(34):6064–6093
Trachootham D, Alexandre J et al (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591
Tsao AS, Garden AS et al (2006) Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol 24(25):4163–4169
Turati F, Garavello W et al (2010) A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: results by subsites. Oral Oncol 46(10):720–726
Tyagi A, Gu M et al (2011) Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res 17(16):5402–5411
Tyagi A, Singh RP et al (2005) Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26(11):1978–1987
Wang M, Chu H et al (2013) Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J Biomed Res 27(3):179–192
Weng CJ, Yen GC (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38(1):76–87
Woutersen RA, Appelman LM et al (1986) Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology 41(2):213–231
Yokoyama A, Muramatsu T et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19(8):1383–1387
Chow, H. H., L. L. Garland, et al. (2010). “Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.” Cancer Prev Res (Phila) 3(9): 1168–1175
Grant Support:
Supported by grants to R. Sclafani from the Fanconi Anemia Research Foundation and the University of Colorado Cancer Center.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Shrotriya, S., Agarwal, R., Sclafani, R.A. (2015). A Perspective on Chemoprevention by Resveratrol in Head and Neck Squamous Cell Carcinoma. In: Vasiliou, V., Zakhari, S., Seitz, H., Hoek, J. (eds) Biological Basis of Alcohol-Induced Cancer. Advances in Experimental Medicine and Biology, vol 815. Springer, Cham. https://doi.org/10.1007/978-3-319-09614-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-09614-8_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09613-1
Online ISBN: 978-3-319-09614-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)